Vertex Reports First-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Vertex Pharma (VRTX) Tops Q1 EPS by 14c; Reiterates Outlook
April 26, 2018 4:08 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q1 EPS of $0.76, $0.14 better than the analyst estimate of $0.62. Revenue for the quarter came in at $638 million versus the consensus estimate of $617.59 million.
Company reiterates full-year 2018 total CF product revenue guidance of $2.65 to $2.80 billion and combined... More



